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 The diagnosis of acute decompensated heart failure (ADHF) in nonselected patients presenting with 
acute dyspnea is challenging. Symptoms and physical 
examination are nonspecifi c and lack the sensitivity to 
make an accurate and reliable diagnosis of heart fail-
ure in dyspneic patients presenting acutely to a med-
ical facility. 1 Although helpful at times, commonly 
available adjunct testing including ECG, chest radi-
ography, and serum troponin does little to improve the 
diagnosis of heart failure. 1-4 Although brain natriuretic 
peptide (BNP) does improve the diagnosis of heart 
failure in some settings, it is affected by age, sex, medi-
cations, and has large indeterminate range. BNP may 
not be diagnostic in cases of fl ash pulmonary edema, 
mitral regurgitation, or obesity. 5,6 Furthermore, the 
clinical assessment correlates poorly with either BNP 
levels or patient outcomes 7 and serial BNP levels are 
of limited value in patient management. 7,8 
 Additional diagnostic accuracy may be obtained from 
echocardiography or invasive hemodynamic monitoring 
but these tools are expensive and may not be available 
in the acute care. The combination of a wide variation 
in hospital admission rates for heart failure 9-13 and 
inaccurate physician estimates of heart failure patient 
risk of death 7 suggest that a more accurate means of 
diagnosis in these patients might improve the appropri-
ateness of admission and treatment decisions. Indeed, 
the ED physician inaccuracy in making the diagnosis 
of ADHF delays appropriate treatment. 7 The ideal 
adjunct for the diagnosis of ADHF would be nonin-
vasive, inexpensive, able to increase the accuracy of 
diagnosis, and provide real-time information about 
 Background:  We compared the ability of noninvasive measurements of cardiac output (CO) and 
thoracic fl uid content (TFC) and their change in response to orthostatic challenges to diagnose 
acute decompensate heart failure (ADHF) from non-ADHF causes of acute dyspnea in patients in 
the ED. 
 Methods:  Forty-fi ve patients  . 44 years old presenting in the ED with dyspnea were studied. CO 
and TFC were monitored with a NICOM bioreactance device. CO and TFC were measured contin-
uously while each patient was sitting, supine, and during a passive leg-raising maneuver (3 min each); 
the maximal values during each maneuver were reported. Orthostatic challenges were repeated 
2 h into treatment. One patient was excluded because of intolerance to the supine position. Diag-
noses obtained with the hemodynamic measurements were compared with ED diagnoses and with 
two expert physicians by chart review (used as gold standard diagnosis); both groups were blinded 
to CO and TFC values. Patient’s treatment, ED disposition, hospital length of stay, and subjective 
dyspnea (Borg scale) were also recorded. 
 Results:  Sixteen of 44 patients received a diagnosis of ADHF and 28 received a diagnosis of non-
ADHF by the experts. Baseline TFC was higher in patients with ADHF ( P  5 .001). Fifteen patients 
were treated for ADHF, and their Borg scale values decreased at 2 h ( P  , .05). TFC threshold 
of 78.8 had a receiver operator characteristic area under the curve of 0.81 (76% sensitivity, 
71% specifi city) for ADHF. Both ADHF and non-ADHF groups were similar in their increased 
CO from baseline to PLR and supine. Pre- and posttreatment measurements were similar. 
 Conclusions:  Baseline TFC can discriminate patients with ADHF from non-ADHF dyspnea in 
the ED.   CHEST 2013; 144(2):610–615 
 Abbreviations:  ADHF  5 acute decompensated heart failure; BNP  5 brain natriuretic peptide; CO  5 cardiac output; 
PLR  5 passive leg raising; ROC  5 receiver operator curve; SV  5 stroke volume; SVI  5 stroke volume index; TFC  5 thoracic 
fl uid content 
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signed informed consent to participate in the study, and no unto-
ward events occurred as a result of subject participation. 
 Study Population 
 Patients   45 years of age presenting to the ED with the pri-
mary or signifi cant complaint of dyspnea or diffi culty breathing 
were included. We chose this age threshold since 97% of acute 
heart failure admissions occur in this age segment and heart fail-
ure in younger patients is often accompanied by other struc-
tural concerns not present in this older population. Furthermore, 
exclud ing patients  , 45 years of age enhances screening effi ciency 
because this younger age group accounts for approximately two-
thirds of all ED visits but only 3% of patients in the ED diagnosed 
with heart failure. 16 
 Exclusion criteria included transfer from another ED or hos-
pital, known pregnancy that would preclude the use of a PLR 
maneuver, shortness of breath from known traumatic cause, lim-
ited code status, clinically unstable patients at the moment of ED 
admission (systolic BP  , 85 mm Hg, heart rate over 1 min  . 120, 
or Sp o 2  , 92%), and having the primary clinical team giving the 
patient the diagnosis of acute coronary syndrome. Although new 
or worsening cardiac ischemia may be the underlying cause for 
new onset or an acute exacerbation of heart failure in patients 
with ADHF, usually clinical practice for patients presenting to the 
ED with chest pain and dyspnea suspected of cardiac origin is 
managed in accordance with hospital chest pain protocols that pre-
clude the time required for the completion of our study. Patients 
were included consecutively when the research team was available 
(business days, from 8:00  am to 12:00  pm ). 
 Bioimpedance/Bioreactance Measurements 
 Mean and PLR-induced changes in CO and TFC were obtained 
using a NICOM device (Cheetah Medical Holdings). The NICOM 
uses four electrodes pairs in both midclavicular lines and both 
lower rib margins. The system requires 2 min to calibrate and has 
no detrimental effects on the patient. Following informed con-
sent, initial CO and TFC measures were made in the fi rst 15 min 
after ED admission while the patient was seated (hips fl exed to 
60° or more). These measures were interpreted as baseline values. 
We then performed a PLR maneuver for 3 min by placing the 
patient in a supine position or as fl at as tolerated (at least   30°) 
and with legs raised to 45°. Finally, patients were placed in the 
supine position without leg raising for another 3 min, and another 
measurement was taken ( Fig 1 ). Those patients diagnosed by 
their ED physician as having ADHF received disease-specifi c 
treatment, which typically included a combination of nitrates, 
diuretics, angiotensin-converting enzyme inhibitors, and contin-
uous or bilevel pressure ventilation. To assess the hemodynamic 
effect of this treatment, an additional set of three orthostatic mea-
sures was taken 2 h after the initial measures. To assess the subjective 
effect of the treatment, patients quantifi ed their dyspnea severity 
using the Borg modifi ed scale that measures the shortness-of-
breath subjective feeling on a numeric scale from 0 (nothing) to 
10 (maximal). 
 Since the maximum hemodynamic effect of a PLR maneuver is 
usually seen in the fi rst 1 to 2 min, 17 we reviewed the CO and TFC 
data over the entire PLR maneuver and reported the highest CO 
and TFC values as the PLR effect. We compared absolute values 
and the changes in TFC and CO between baseline, PLR maneuver, 
and sitting to supine position for their ability to discriminate ADHF 
from non-ADHF diagnoses. 
 Additional Tests 
 We also collected physical examination data, ECG, and labo-
ratory (including BNP if done) results, the Rapid Emergency 
both the severity of the illness and its response to 
emergent treatment. 
 One such adjunct may be noninvasive assessment of 
cardiac output (CO) and thoracic fl uid content (TFC) 
using bioreactance, based on measurement of phase 
shift in a high-frequency, low-voltage current conducted 
into the chest cavity though a series of external elec-
trodes. Bioreactance uses changes in chest fl uid con-
tent associated with changes in thoracic capacitance 
and inductive properties to estimate CO and TFC. 
This noninvasive method of CO monitoring was com-
pared in several studies to thermodilution using a 
pulmonary artery catheter 14,15 documenting good cor-
relation (R  5 0.82) and minimal bias (  4%) (11) and 
a three times faster response rate. 
 Because ADHF may present with a wide range of 
individual CO values, knowing absolute values may 
not be sensitive or specifi c enough to discriminate 
among other causes of dyspnea. Using functional hemo-
dynamic monitoring such as TFC and the dynamic 
changes in CO and TFC in response to a calibrated 
orthostatic challenge, such as passive leg-raising maneu-
ver (PLR), should increase the utility of the bioreac-
tance measures in identifying acute decompensation 
and discriminating among other noncardiac dyspnea 
etiologies. 
 We hypothesized that dynamic changes in CO and 
TFC induced by PLR would be quantitatively different 
between patients with cardiac and noncardiac causes 
of dyspnea. Specifi cally, patients with ADHF would 
display a higher TFC and decreased variability in 
both CO and TFC than patients who do not have 
ADHF dyspnea. 
 Materials and Methods 
 After University of Pittsburgh institutional review board 
approval (IRB0701090), we performed a prospective observa-
tional study of patients presenting with a chief complaint of dys-
pnea to the ED of an academic tertiary care center. All subjects 
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 Results 
 Forty-fi ve patients were included in the study over 
6 months (April-August 2010). One patient was excluded 
after initial inclusion due to intolerance to the ortho-
static challenge maneuvers. Dynamic (but not baseline) 
TFC changes in the fi rst 15 patients were discarded due 
to technical problems during the orthostatic challenges 
with the initial Bioreactance software program. The 
expert reviewers classifi ed post hoc 16 patients as 
ADHF and 28 as non-ADHF.  Table 1 shows the patient 
demographic data. 
 Although baseline heart rate was higher in patients 
without ADHF, there were not signifi cant differences 
in stroke volume (SV) and stroke volume index (SVI) 
with the orthostatic challenges among the two diag-
nostic groups ( Table 2 ) nor in the difference between 
maneuvers ( D baseline to PLR and  D baseline to supine) 
( Table 3 ). 
 TFC was signifi cantly higher at baseline in patients 
with ADHF ( P  5 .001) ( Fig 2 ) and remained higher 
during the orthostatic maneuvers. The baseline TFC 
value showed ROC area under the curve of 0.81 that 
was higher than the ED physician accuracy for ADHF 
diagnosis (0.74). We found a cutoff TFC value of 
78.8 1/kW in baseline, having 76% sensitivity, 71% spec-
ifi city, positive likelihood ratio of 2.6, and a negative 
likelihood ratio of 0.3 ( Fig 3 ). 
 We found a moderate agreement (77%) between 
ED physicians and the expert reviewers ( k , 0.46), indi-
cating that the accuracy of ADHF diagnosis by ED 
physicians remains limited. Those patients who were 
correctly diagnosed and treated as ADHF showed a sig-
nifi cant decrease in the Borg modifi ed scale dyspnea 
subjective perception (from 5   2 to 3   2,  P  , .05). 
There were no signifi cant differences in the hemody-
namic parameters. 
 BNP was measured in seven patients. However, it 
was more frequently measured in those patients with 
Medicine Score, and any additional inpatient data related to 
ADHF diagnosis. 
 ED physicians were blinded to the NICOM data. We collected 
the ED discharge diagnosis, hospital admission or ICU admission 
diagnosis and inpatient deaths, serious medical complications that 
occurred before hospital discharge, and hospital discharge date 
used to calculate hospital free days (over 30). Inpatient death was 
considered 0. 
 Outcome Adjudication 
 Diagnosis as ADHF or non-ADHF was determined by two car-
diologists expert in heart failure diagnosis, after a retrospective 
review of patient’s medical chart with full access to all the adjunc-
tive tests made to the patient during hospital stay, but blinded to 
both the CO and TFC results and the ED physician’s diagnosis. 
These independent reviewers provided scores obtained using the 
Framingham 18 and National Health and Nutrition Examination 
Survey heart failure clinical score 19 to identify patients with heart 
failure. Both cardiologists had to agree in one diagnosis after a 
separated review of medical records. In case of disagreement, the 
experts were asked to meet and reach a common diagnosis. In prac-
tice, both cardiologists reached the same diagnosis on all patients 
during their independent reviews. The ED physician’s diagnosis 
refl ects the diagnosis for ED discharge or hospital admission as 
made by the attending ED physician. 
 Statistical Methods 
 We compared both the ED physician diagnosis and those 
assigned based on initial CO and TFC values against the diag-
nosis obtained by two independent reviewers by  x 2 testing.  a was 
defi ned as  P  , .05. Baseline characteristics used mean values and 
proportions. We compared ED physician diagnosis based on ini-
tial impression and with the addition of laboratories and clinical 
data to the orthostatic CO and TFC data using a two-sample  t test. 
 x 2 testing and ORs were computed to compare the orthostatic CO 
and TFC data vs the diagnosis defi ned by the expert reviewers. We 
generated receiver operator curves (ROCs) for physician assess-
ment, orthostatic CO, orthostatic TFC, and combined orthostatic 
CO and TFC. We used the Cohen  k index to assess the agreement 
between expert diagnosis of ADHF and ED physician diagnosis. 
 Figure 1. Orthostatic maneuvers. PLR  5 passive leg raising. 
 Table 1— Demographic Data Separated by Expert 
Diagnosis of Dyspnea 
Demographics 
Expert Diagnosis
ADHF (n  5 16) Non-ADHF (n  5 28)
Age, y 65   11 60   12
Sex, M (F) 9 (7) 11 (17)
BSA, m 2 1.95   0.28 1.83   0.27
Heart rate, bpm 74   16 88   18
Respiratory rate, breaths/min 22   4 19   3
Systolic BP, mmHg 140   29 134   27
Sa o 2 , % 96   2% 97   2%
Borg scale 4   3 5   2
REMS score 6.8   2.2 5.6   2.4
Values (except sex) expressed in mean   SD. ADHF  5 acute decom-
pensated heart failure; bpm  5 beats per min; BSA  5 body surface area; 
F  5 female; M  5 male; REMS  5 Rapid Emer gency Medicine Score; 
Sa o 2   5 pulse oximetry oxygen saturation.
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 Our reference ADHF diagnosis was retrospective 
chart review by two expert cardiologists; Engineer et al 20 
used either ED physician diagnosis combined with 
BNP, or only BNP levels  . 500 pg/mL. Regrettably, 
ED physician diagnosis accuracy is not higher than 
80% and even combined to BNP is only 82.5%. 6 Our 
study corroborates their fi ndings because our ROC 
showed accuracy for ED physician diagnosis of 0.74, 
although BNP was rarely measured in the subjects. 
This low accuracy and the moderate agreement found 
between ED physician and expert reviewer diagnosis 
underscores the necessity of diagnostic tools to help 
ED physicians accurately make the ADHF diagnosis. 
The fact that, in our study, those patients who received 
mismatched treatment of ADHF had less symptom 
improvement further emphasizes this necessity. Our 
study demonstrates that baseline TFC could be such 
a valid tool. 
 Another important difference between our study and 
the one by Engineer et al 20 is that we had very restric-
tive exclusion criteria regarding clinical instabil ity, 
while in their study even patients with the greatest 
severity of illness were not excluded. Thus, it is pos-
sible that their patients with ADHF were more severe 
than in our sample, and this could explain why their 
patients with ADHF had the lower cardiac index 
response to the orthostatic challenges. 
 Study Limitations 
 Although the NICOM CO and TFC measurements 
are already validated, CO and TFC measures use dif-
ferent analyses. CO measures are based on bioreac-
tance (phase shift in the oscillating electrical fi eld), 
whereas TFC is based in bioimpedance. Bioimpedance 
a fi nal diagnosis of ADHF (37.5% vs 3.6%). In addition, 
71.4% of patients not diagnosed with ADHF were 
admitted, as well as 93.3% of those diagnosed by the 
experts as ADHF. There was no signifi cant difference 
in hospital-free days between ADHF and non-ADHF 
groups (25   5 days vs 26   5 days). 
 Discussion 
 We found a signifi cant difference in baseline TFC 
but not CO between patients diagnosed with ADHF 
and those not diagnosed with ADHF presenting to 
the ED with acute dyspnea. However, we also found 
no difference in either  D TFC or  D CO in response to 
an orthostatic challenge between ADHF and non-
ADHF groups. Although CO increased with supine 
and PLR maneuvers compared with baseline, the 
increase was not different between patient groups. 
That only one patient of 45 did not tolerate the supine 
position and PLR maneuvers documents that these 
orthostatic challenges are safe for patients with dys-
pnea presenting to the ED. 
 Our data are only in partial agreement with those 
previously reported by Engineer et al. 20 They found a 
similar increased baseline TFC in patients with ADHF 
compared with their patients with COPD who did 
not have ADHF. Presumably, these differences refl ect 
differences in methodologies. First, we used both the 
supine position and a PLR maneuver to provoke the 
dynamic changes in venous return, while Engineer et al 20 
used only the dynamic change from sitting (hips fl exed 
to 90°) to supine position or as fl at as tolerated. Still, 
in our study, TFC remained signifi cantly higher in 
patients with ADHF during both challenges. 
 Table 2— Hemodynamic Values at Baseline (30° Trunk Elevation), PLR, and in Supine Position 
Value
Baseline PLR Supine
ADHF Non-ADHF  P Value ADHF Non-ADHF  P Value ADHF Non-ADHF  P Value
Heart rate, bpm 74   16 88   18 .02 75   16 87   18 .04 75   16 86   18 .06
SV, mL 79   28 72   25 .36 91   43 78   26 .23 86   33 77   25 .30
SVI, mL/m 2 40   11 39   10 .07 45   17 42   11 .21 43   13 42   11 .17
TFC, 1/kW 94   22 71   31 .001 93   21 72   33 .002 94   22 73   39 .002
Values expressed in mean   SD. PLR  5 passive leg raising; SV  5 stroke volume; SVI  5 stroke volume index; TFC  5 thoracic fl uid content. See 
Table 1 legend for expansion of other abbreviations.
 Table 3— Variation in Bioreactance/Biompedance Parameters With Orthostatic Changes 
Parameter
 D From Baseline to PLR  D From Baseline to Supine
ADHF, % Non-ADHF, %  P Value ADHF, % Non-ADHF, %  P Value
SV 11   16 9   14 ns 8   14 9   22 ns
SVI 11   16 9   15 ns 9   22 9   15 ns
TFC 0   2 1   4 ns 0   2 3   6 ns
Values expressed in percentage   SD. ns  5 not signifi cant. See Table 1 and 2 legends for expansion of other abbreviations.
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